[New glucose-lowering drugs for reducing cardiovascular risk in patients with type2 diabetes mellitus]
{{output}}
Cardiovascular (CV) disease is the most common cause of mortality in patients with type2 diabetes (T2DM). In recent years, several glucose-lowering drugs from two therapeutic families, GLP-1 receptor agonists (GLP-1 RAs) and sodium-glucose co-transporter type ... ...
